Xenetic Biosciences is a biopharma company advancing immuno-oncology technologies for hard-to-treat cancers. Its proprietary DNase platform targets NETs to enhance existing therapies for pancreatic cancer and advanced solid tumors.
Advertisement|Remove ads.